688105.SS
688105.SS
CNE100004ZK3
NANJING VAZYME BIOTECH CO LTD
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
13.75B EUR
8.97B EUR
7.78B EUR
7.96B EUR
Enterprise Value
11.9B EUR
9.22B EUR
7.88B EUR
8B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
72.04x
--
--
--
Price to Sales
9.34x
7.97x
7.28x
7.72x
Price to Book
3.81x
2.48x
2.05x
2.1x
EV/Revenue
8.09x
8.18x
7.38x
7.75x
EV/EBITDA
-2,187.89x
662.97x
1,245.18x
--
Price to FCF (P/FCF)
61.85x
52.9x
64.13x
57.22x
EV/FCF
53.54x
54.35x
64.97x
57.49x
FCF Yield
1.62%
1.89%
1.56%
1.75%
ende